This year marks roughly fifty years since the modern biotechnology era began — an era defined by recombinant DNA, monoclonal antibodies, genomics, and platform technologies once belonging to science fiction. Biotech has transformed what it means to diagnose, treat, and prevent disease. Faith in that innovation is a promise made to patients, and momentum has […]
This year marks roughly fifty years since the modern biotechnology era began — an era defined by recombinant DNA, monoclonal antibodies, genomics, and platform technologies once belonging to science fiction. Biotech has transformed what it means to diagnose, treat, and prevent disease. Faith in that innovation is a promise made to patients, and momentum has […]
<iframe src="https://statesidedaily.com/embed/cluster/c0a90423625d382f090e4ce492aeaf5e97c3c351" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Fifty years of modern biotech, and an appetite for change"></iframe>
